Stay updated on Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a minor patch to the page's documentation. This does not reflect a substantive change to content or features.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page updated its revision label from v3.6.3 to v3.6.4, reflecting a new build/version in the site metadata. This change represents a minor update to the page's underlying versioning information rather than any user-facing content.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a newer published revision of the page. This reflects a minor update to the page rather than changes to the study content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now shows revision v3.6.2 instead of v3.6.0, indicating a platform update behind the scenes. This change does not alter the study details or user-facing content.SummaryDifference0.0%

- Check62 days agoChange DetectedRecruitment status changed to 'No longer looking for participants', indicating the study is no longer enrolling. The page also adds help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and updates the Interventions heading to 'Intervention/Treatment' with a new page revision (v3.6.0, removing v3.5.5).SummaryDifference0.4%

- Check69 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a small update to the page's version label.SummaryDifference0.0%

Stay in the know with updates to Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.